Actuate Therapeutics, Inc. Common stock Net Asset Momentum
Actuate Therapeutics, Inc. Common stock net asset momentum. Actuate Therapeutics, Inc. Common stock (ACTU) recorded a net asset momentum of 100.1% as of December 2024, with net assets of $104.19K USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Actuate Therapeutics, Inc. Common stock debt service capacity to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Actuate Therapeutics, Inc. Common stock (2022–2024)
Net asset momentum of Actuate Therapeutics, Inc. Common stock from 2022 to 2024. This chart tracks Actuate Therapeutics, Inc. Common stock's year-over-year net asset growth across 3 annual reporting periods from 2022 to 2024. The most recent momentum reading is +100.1%, with net assets of $104.19K USD as of December 2024. See ACTU net asset value for net asset value and shareholders' equity analysis.
Actuate Therapeutics, Inc. Common stock Net Asset Momentum by Year (2022–2024)
Actuate Therapeutics, Inc. Common stock net asset momentum by year from 2022 to 2024. The table below shows the complete annual net asset history for Actuate Therapeutics, Inc. Common stock from 2022 to 2024, covering 3 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see ACTU stock market capitalisation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $104.19K | $9.32 Million | $9.21 Million | ▲ +100.1% |
| 2023 | $-99.63 Million | $3.00 Million | $102.62 Million | ▼ -771.7% |
| 2022 | $14.83 Million | $20.48 Million | $5.65 Million | — |